Literature DB >> 33272829

Fukutin-Related Protein: From Pathology to Treatments.

Carolina Ortiz-Cordero1, Karim Azzag2, Rita C R Perlingeiro3.   

Abstract

Fukutin-related protein (FKRP) is a glycosyltransferase involved in the functional glycosylation of α-dystroglycan (DG), a key component in the link between the cytoskeleton and the extracellular matrix (ECM). Mutations in FKRP lead to dystroglycanopathies with broad severity, including limb-girdle and congenital muscular dystrophy. Studies over the past 5 years have elucidated the function of FKRP, which has expanded the number of therapeutic opportunities for patients carrying FKRP mutations. These include small molecules, gene delivery, and cell therapy. Here we summarize recent findings on the function of FKRP and describe available models for studying diseases and testing therapeutics. Lastly, we highlight preclinical studies that hold potential for the treatment of FKRP-associated dystroglycanopathies.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  congenital muscular dystrophy; dystroglycanopathy; glycosylation; limb-girdle; muscular dystrophy; α-dystroglycan

Mesh:

Substances:

Year:  2020        PMID: 33272829      PMCID: PMC8657196          DOI: 10.1016/j.tcb.2020.11.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  102 in total

Review 1.  Dystroglycan: from biosynthesis to pathogenesis of human disease.

Authors:  Rita Barresi; Kevin P Campbell
Journal:  J Cell Sci       Date:  2006-01-15       Impact factor: 5.285

2.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

Authors:  M Brockington; D J Blake; P Prandini; S C Brown; S Torelli; M A Benson; C P Ponting; B Estournet; N B Romero; E Mercuri; T Voit; C A Sewry; P Guicheney; F Muntoni
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

Review 3.  Update in Duchenne and Becker muscular dystrophy.

Authors:  Megan A Waldrop; Kevin M Flanigan
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

4.  Phenotypic spectrum associated with mutations in the fukutin-related protein gene.

Authors:  Eugenio Mercuri; Martin Brockington; Volker Straub; Susana Quijano-Roy; Yeliz Yuva; Ralf Herrmann; Susan C Brown; Silvia Torelli; Victor Dubowitz; Derek J Blake; Norma B Romero; Brigitte Estournet; Caroline A Sewry; Pascale Guicheney; Thomas Voit; Francesco Muntoni
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

5.  Functional and cellular localization diversity associated with Fukutin-related protein patient genetic variants.

Authors:  Sara F Henriques; Evelyne Gicquel; Justine Marsolier; Isabelle Richard
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.878

6.  Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.

Authors:  Miao Yu; Yonglin He; Kejian Wang; Peng Zhang; Shengle Zhang; Huaiyu Hu
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

7.  Membrane organization of the dystrophin-glycoprotein complex.

Authors:  J M Ervasti; K P Campbell
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

8.  Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.

Authors:  Lei Xu; Pei Juan Lu; Chi-Hsien Wang; Elizabeth Keramaris; Chunping Qiao; Bin Xiao; Derek J Blake; Xiao Xiao; Qi Long Lu
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

9.  Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.

Authors:  Yung-Yao Lin; Richard J White; Silvia Torelli; Sebahattin Cirak; Francesco Muntoni; Derek L Stemple
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

10.  ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice.

Authors:  Marcela P Cataldi; Anthony Blaeser; Peijuan Lu; Victoria Leroy; Qi Long Lu
Journal:  Mol Ther Methods Clin Dev       Date:  2019-12-24       Impact factor: 6.698

View more
  3 in total

1.  NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.

Authors:  Carolina Ortiz-Cordero; Alessandro Magli; Neha R Dhoke; Taylor Kuebler; Sridhar Selvaraj; Nelio Aj Oliveira; Haowen Zhou; Yuk Y Sham; Anne G Bang; Rita Cr Perlingeiro
Journal:  Elife       Date:  2021-01-29       Impact factor: 8.140

2.  Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies.

Authors:  Carolina Ortiz-Cordero; Claudia Bincoletto; Neha R Dhoke; Sridhar Selvaraj; Alessandro Magli; Haowen Zhou; Do-Hyung Kim; Anne G Bang; Rita C R Perlingeiro
Journal:  Stem Cell Reports       Date:  2021-10-14       Impact factor: 7.765

3.  A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.

Authors:  Neha R Dhoke; Hyunkee Kim; Sridhar Selvaraj; Karim Azzag; Haowen Zhou; Nelio A J Oliveira; Sudheer Tungtur; Carolina Ortiz-Cordero; James Kiley; Qi Long Lu; Anne G Bang; Rita C R Perlingeiro
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.